Company / Interest Expense
iBio, Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$83.0K
FY2023
5-year range
$83.0K / $2.5M
FY2019-FY2023
Trend
-96.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 8 years, ranging from $0 in FY2016 to $2M in FY2021.
Based on SEC 10-K filings.
$83,000 in FY2023 with a 5-year CAGR of -46.7%.
Improved from $2M to $83,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -64.8%
- 5-Year CAGR
- -46.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -46.7%, indicating a declining trend.
- In FY2023, interest expense decreased 96.6% year-over-year.
- Peak interest expense was recorded in FY2021.
- Lowest interest expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $83.0K | -96.6% |
| FY2022 | $2.5M | -0.5% |
| FY2021 | $2.5M | +29.8% |
| FY2020 | $1.9M | -0.8% |
| FY2019 | $1.9M | -0.7% |
| FY2018 | $1.9M | +139.0% |
| FY2017 | $807.0K | - |
| FY2016 | $0 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026